70 likes | 299 Views
September 24, 1998 Presented by: Aldo Baumgartner, President & CEO, Wyeth-Ayerst Canada Leonard Marks, Vice-President, Cosmetics & Pharmacy, London Drugs. ECR x in the Drug Channel. STAKEHOLDER COMMITTEE. Co-Chairs Leonard Marks London Drugs Ltd.
E N D
September 24, 1998 Presented by: Aldo Baumgartner, President & CEO, Wyeth-Ayerst Canada Leonard Marks, Vice-President, Cosmetics & Pharmacy, London Drugs ECRx in the Drug Channel
STAKEHOLDER COMMITTEE Co-Chairs Leonard Marks London Drugs Ltd. Aldo Baumgartner Wyeth-Ayerst Canada Committee Larry Andrews AltiMed Pharmaceuticals Chris Bisanz FCPMC David Bloom Shoppers Drug Mart Ltd. Claudio Bussandri Medis Don Cameron Lawtons Drug Stores François Coutu Le Groupe Jean Coutu Brenda Drinkwalter CDMA Judy Erola PMAC Jeremy Ferdinands Overwaitea Food Group Frank Ferlaino Cosmair Leroy Fevang CPhA Theresa Firestone CWDA Ronald Frisch Kohl & Frisch
STAKEHOLDER COMMITTEE …cont’d Co-Chairs Leonard Marks London Drugs Ltd. Aldo Baumgartner Wyeth-Ayerst Canada Committee Colleen Jay Procter & Gamble Steve Johnson Mead Johnson Jack Kay Apotex Charles Low CCTFA John Makepeace Wal-Mart Canada Inc. Gerry McDole Astra Pharma Inc. Malcolm Seath Whitehall Robins Monika Simon CACDS Art Smith ECCC Gersh Sone Pharmx Rexall Robert White NDMAC
ECRxCATEGORIES • Rx • OTCs • Cosmetics
ECRxENABLERS • Barcoding • Electronic Data Interchange (EDI) • Central Product Catalogue • Scorecarding